Trial intelligence / Profile preview

Tongluo Jiuna Injection in Acute Cerebral Infarction Phase II Trial

CTR20131882Phase 2Completed

Sponsor
Inner Mongolia Kangyuan Pharmaceutical
Start
Jan 2014
Countries
1
01

Overview

A Phase 2 trial of Tongluo Jiunao in brain infarction, ischemic stroke, sponsored by Inner Mongolia Kangyuan Pharmaceutical. Started Jan 2014; status: completed.

02

Drugs

Tongluo Jiunao
03

Conditions

brain infarctionischemic stroke

Beyond the preview

Go deeper on CTR20131882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call